ArticleCureus2025
Toupet Fundoplication With Re-sleeve for Hiatal Hernia Associated With Failed Sleeve Gastrectomy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSleeve gastrectomy (SG) may induce or worsen gastroesophageal reflux disease (GERD), especially with coexisting hiatal hernia (HH). Evidence on combining Toupet fundoplication with re-sleeving is limited.
objectiveTo assess the safety and effectiveness of Toupet fundoplication plus re-sleeve for reflux control and weight loss after failed SG with HH.
methodsProspective single-center series of 20 adults (30-60 years) with failed SG (≤50% excess weight loss at one year and/or BMI >35 kg/m²) and medically refractory GERD. Preoperative workup included endoscopy and contrast imaging. Surgery entailed complete hiatal dissection, posterior cruroplasty, 270° (Toupet) fundoplication using residual fundus with fixation to the crura, and re-sleeve over a 36-Fr bougie. The outcomes considered were: GERD resolution, complications, excess weight loss (EWL%) at three, six, and 18 months, and changes in comorbidities.
resultsThe mean age of the patients was 42.8 years, 65% of the total patients were females, and the follow-up period was 18 months. HH was confirmed perioperatively in 55%; all had symptomatic GERD. The mean operative time was 100±22.6 minutes, and the hospital stay was 40±18.7 hours. No leaks, bleeding, reoperation, or mortality were observed; transient nausea in 40% resolved conservatively. GERD was resolved in 65% of the patients, 25% required proton pump inhibitors (PPIs) for three months, and 10% for six months, then as needed. No HH recurrence was observed. The excess weight loss percentage (EWL%) observed was as follows: 21% (three months), 42% (six months), 63.2% (18 months). Antihypertensives were discontinued. Diabetes remitted in 10% patients with dose reduction in one additional patient.
conclusionToupet fundoplication with re-sleeve appears to be a safe and effective option for controlling GERD and promoting weight loss after failed SG with HH. Larger comparative studies are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.